Jun 2026 (Q2 FY26) — Aug 3, 2026
Inspire Medical Systems Q2 FY26 — Strong Q2 Performance and Project Horizon Launch Amidst Reimbursement Headwinds
Read the full callInspire Medical Systems (INSP) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Inspire Medical Systems earnings: last reported Mon, 3 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 201 | −7.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -0.3 | +1.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 0.31 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$70.12 +3.01% · +$2.05
Performance −11.1% 1Y
1Y: $78.84 on 14 Oct 2025 → $70.12. High $143.99 (8 Dec 2025), low $40.05 (15 May 2026).
- Previous close
- $68.07
- 52-week range
- $40.05 – $143.99
- One year
- −11.06%
Overview
- Symbol
- INSP
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Inspire Medical Systems earnings calls (INSP)
Financials
What the filings say
Net profit, year on year: +109% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 203 | 240 | 201 | 217 | 225 | 269 | 205 | 201 |
| Operating profit | 14 | 32 | -1 | -3 | 10 | 46 | -1 | -1 |
| Operating margin | 7.0% | 13.3% | −0.7% | −1.5% | 4.3% | 17.1% | −0.6% | −0.3% |
| Other income | 6 | 5 | 6 | 1 | 4 | 4 | — | — |
| Interest | 0 | — | — | 0 | 0 | 0 | — | — |
| Profit before tax | 20 | 37 | 4 | -2 | 14 | 50 | 2 | 3 |
| Tax rate | 9.0% | 3.9% | 28.1% | −54.0% | 26.7% | −170.4% | 571.2% | 89.9% |
| Net profit | 18 | 35 | 3 | -4 | 10 | 136 | -11 | 0 |
| EPS ($ per share) | 0.62 | — | 0.10 | -0.12 | 0.34 | — | -0.39 | 0.01 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -147 | -180 | -237 | -279 | -324 | -345 | -292 | -146 |
| Total liabilities | 36 | 41 | 51 | 66 | 69 | 104 | 119 | 126 |
| Fixed assets | 1 | 3 | 5 | 8 | 17 | 40 | 72 | 98 |
| Investments | 91 | 127 | 44 | 0 | 10 | 275 | 295 | 203 |
| Total assets | 200 | 181 | 281 | 295 | 565 | 677 | 808 | 907 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -19 | -33 | -53 | -20 | 12 | 25 | 130 | 117 |
| Cash from investing | -83 | -44 | 87 | 29 | -20 | -295 | -113 | 21 |
| Cash from financing | 190 | 2 | 134 | 15 | 235 | 14 | -52 | -183 |
| Net cash flow | 88 | -74 | 168 | 24 | 227 | -256 | -35 | -45 |
| Capital expenditure | -0 | -3 | -2 | -5 | -9 | -24 | -39 | -38 |
| Free cash flow | -19 | -36 | -55 | -25 | 2 | 1 | 91 | 78 |
Insider filings
59 filings between Nov 28, 2025 and Aug 31, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$666.0K
7 sales by 3 insiders
57% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 34
- Award — granted as compensation
- 18
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| McCormick Shawn | — | $453.3K | May 8, 2026 |
| Rondoni John | — | $155.3K | May 15, 2026 |
| Kelly Jason P | — | $57.3K | Aug 7, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Kelly Jason P See Remarks | Award | 6,350 | $0 |
| Aug 7, 2026 | Kelly Jason P See Remarks | Sale | 963 | $57.3K |
| Jul 31, 2026 | Mann Melissa Chief People Officer | Tax withheld | 326 | $16.4K |
| Jul 20, 2026 | CARREL MICHAEL H Director | Award | 5,631 | $0 |
| Jul 15, 2026 | Ellis Gary Lee Director | Award | 581 | $0 |
| Jul 15, 2026 | Broader Shelley G. Director | Award | 383 | $0 |
| Jul 15, 2026 | Melenikiotou Georgia Director | Award | 344 | $0 |
| Jul 15, 2026 | Tansey Casey M Director | Award | 346 | $0 |
| May 15, 2026 | Rondoni John See Remarks | Sale | 2,641 | $114.3K |
| May 14, 2026 | Rondoni John See Remarks | Sale | 700 | $30.1K |
| May 8, 2026 | McCormick Shawn Director | Sale 10b5-1 plan | 696 | $31.5K |
| May 1, 2026 | Melenikiotou Georgia Director | Tax withheld | 50 | $2.8K |
| Apr 30, 2026 | McCormick Shawn Director | Award 10b5-1 plan | 3,562 | $0 |
| Apr 30, 2026 | Broader Shelley G. Director | Award | 3,562 | $0 |
| Apr 30, 2026 | Melenikiotou Georgia Director | Award | 3,562 | $0 |
| Apr 30, 2026 | Burks Cynthia Director | Award | 3,562 | $0 |
| Apr 30, 2026 | Mead Dana G Jr. Director | Award | 3,562 | $0 |
| Apr 30, 2026 | Tansey Casey M Director | Award | 3,562 | $0 |
| Apr 30, 2026 | Ellis Gary Lee Director | Award | 3,562 | $0 |
| Apr 30, 2026 | Curet Myriam Director | Award | 3,562 | $0 |
| Apr 15, 2026 | Broader Shelley G. Director | Award | 342 | $17.8K |
| Apr 15, 2026 | Melenikiotou Georgia Director | Award | 307 | $16.0K |
| Apr 15, 2026 | Ellis Gary Lee Director | Award | 518 | $27.0K |
| Apr 15, 2026 | Tansey Casey M Director | Award | 308 | $16.0K |
| Feb 20, 2026 | Weatherby Carlton See Remarks | Award | 20,997 | $0 |
| Feb 20, 2026 | Weatherby Carlton See Remarks | Tax withheld | 672 | $40.0K |
| Feb 20, 2026 | Weatherby Carlton See Remarks | Award | 2,196 | $0 |
| Feb 20, 2026 | Rondoni John See Remarks | Award | 15,958 | $0 |
| Feb 20, 2026 | Rondoni John See Remarks | Award | 2,400 | $0 |
| Feb 20, 2026 | Weatherby Carlton See Remarks | Award | 12,598 | $0 |
| Feb 20, 2026 | Rondoni John See Remarks | Tax withheld | 735 | $43.8K |
| Feb 20, 2026 | Herbert Timothy P. CEO and President | Award | 62,153 | $0 |
| Feb 20, 2026 | Mann Melissa Chief People Officer | Award | 15,958 | $0 |
| Feb 20, 2026 | Herbert Timothy P. CEO and President | Award | 9,005 | $0 |
| Feb 20, 2026 | Phillips Bryan K See Remarks | Award | 8,399 | $0 |
| Feb 20, 2026 | Phillips Bryan K See Remarks | Award | 15,958 | $0 |
| Feb 20, 2026 | Phillips Bryan K See Remarks | Tax withheld | 735 | $43.8K |
| Feb 20, 2026 | Herbert Timothy P. CEO and President | Tax withheld | 4,010 | $238.7K |
| Feb 20, 2026 | Phillips Bryan K See Remarks | Award | 2,400 | $0 |
| Feb 20, 2026 | Kelly Jason P See Remarks | Award | 15,958 | $0 |
| Feb 13, 2026 | Herbert Timothy P. CEO and President | Tax withheld | 1,635 | $97.7K |
| Feb 13, 2026 | Mann Melissa Chief People Officer | Tax withheld | 615 | $36.8K |
| Feb 13, 2026 | Rondoni John See Remarks | Tax withheld | 587 | $35.1K |
| Feb 13, 2026 | Kelly Jason P See Remarks | Tax withheld | 551 | $32.9K |
| Feb 13, 2026 | Weatherby Carlton See Remarks | Tax withheld | 570 | $34.1K |
| Feb 13, 2026 | Buchholz Richard Interim CFO | Tax withheld | 579 | $34.6K |
| Feb 13, 2026 | Phillips Bryan K See Remarks | Tax withheld | 579 | $34.6K |
| Feb 9, 2026 | Herbert Timothy P. CEO and President | Tax withheld | 968 | $64.2K |
| Feb 9, 2026 | Rondoni John See Remarks | Tax withheld | 327 | $21.7K |
| Feb 9, 2026 | Buchholz Richard Interim CFO | Tax withheld | 327 | $21.7K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Inspire Medical Systems, Inc.
Free account. Everything above stays public.
Write why you follow Inspire Medical Systems, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading